476 related articles for article (PubMed ID: 30944142)
1. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, combined or not with use of a bundle of new devices, for prevention of short-term peripheral venous catheter-related infectious complications and catheter failure: an open-label, single-centre, randomised, four-parallel group, two-by-two factorial trial: CLEAN 3 protocol study.
Guenezan J; Drugeon B; O'Neill R; Caillaud D; Sénamaud C; Pouzet C; Seguin S; Frasca D; Mimoz O
BMJ Open; 2019 Apr; 9(4):e028549. PubMed ID: 30944142
[TBL] [Abstract][Full Text] [Related]
2. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial.
Guenezan J; Marjanovic N; Drugeon B; Neill RO; Liuu E; Roblot F; Palazzo P; Bironneau V; Prevost F; Paul J; Pichon M; Boisson M; Frasca D; Mimoz O;
Lancet Infect Dis; 2021 Jul; 21(7):1038-1048. PubMed ID: 33539734
[TBL] [Abstract][Full Text] [Related]
3. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Mimoz O; Lucet JC; Kerforne T; Pascal J; Souweine B; Goudet V; Mercat A; Bouadma L; Lasocki S; Alfandari S; Friggeri A; Wallet F; Allou N; Ruckly S; Balayn D; Lepape A; Timsit JF;
Lancet; 2015 Nov; 386(10008):2069-2077. PubMed ID: 26388532
[TBL] [Abstract][Full Text] [Related]
4. Skin antisepsis for reducing central venous catheter-related infections.
Lai NM; Lai NA; O'Riordan E; Chaiyakunapruk N; Taylor JE; Tan K
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010140. PubMed ID: 27410189
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
Goudet V; Timsit JF; Lucet JC; Lepape A; Balayn D; Seguin S; Mimoz O
Trials; 2013 Apr; 14():114. PubMed ID: 23782845
[TBL] [Abstract][Full Text] [Related]
6. Multicentre, open-label, randomised, controlled clinical trial comparing 2% chlorhexidine-70% isopropanol and 5% povidone iodine-69% ethanol for skin antisepsis in reducing surgical-site infection after cardiac surgery: the CLEAN 2 study protocol.
Boisson M; Corbi P; Kerforne T; Camilleri L; Debauchez M; Demondion P; Eljezi V; Flecher E; Lepelletier D; Leprince P; Nesseler N; Nizou JY; Roussel JC; Rozec B; Ruckly S; Lucet JC; Timsit JF; Mimoz O
BMJ Open; 2019 Jun; 9(6):e026929. PubMed ID: 31213447
[TBL] [Abstract][Full Text] [Related]
7. Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial.
Rickard CM; Marsh NM; Webster J; Gavin NC; Chan RJ; McCarthy AL; Mollee P; Ullman AJ; Kleidon T; Chopra V; Zhang L; McGrail MR; Larsen E; Choudhury MA; Keogh S; Alexandrou E; McMillan DJ; Mervin MC; Paterson DL; Cooke M; Ray-Barruel G; Castillo MI; Hallahan A; Corley A; Geoffrey Playford E
BMJ Open; 2017 Jun; 7(6):e015291. PubMed ID: 28619777
[TBL] [Abstract][Full Text] [Related]
8. One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
Ohtake S; Takahashi H; Nakagawa M; Uchino Y; Miura K; Iriyama N; Nakayama T; Hatta Y; Takei M
J Infect Chemother; 2018 Jul; 24(7):544-548. PubMed ID: 29627326
[TBL] [Abstract][Full Text] [Related]
9. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.
Casey AL; Worthington T; Lambert PA; Quinn D; Faroqui MH; Elliott TS
J Hosp Infect; 2003 Aug; 54(4):288-93. PubMed ID: 12919759
[TBL] [Abstract][Full Text] [Related]
10. Infection: Efficacy of chlorhexidine against catheter-related infections.
Edwards JK
Nat Rev Nephrol; 2015 Nov; 11(11):632. PubMed ID: 26434403
[No Abstract] [Full Text] [Related]
11. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
[TBL] [Abstract][Full Text] [Related]
12. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients.
Vallés J; Fernández I; Alcaraz D; Chacón E; Cazorla A; Canals M; Mariscal D; Fontanals D; Morón A
Infect Control Hosp Epidemiol; 2008 Sep; 29(9):847-53. PubMed ID: 18665819
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters.
Maki DG; Ringer M; Alvarado CJ
Lancet; 1991 Aug; 338(8763):339-43. PubMed ID: 1677698
[TBL] [Abstract][Full Text] [Related]
15. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery.
Dumville JC; McFarlane E; Edwards P; Lipp A; Holmes A; Liu Z
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD003949. PubMed ID: 25897764
[TBL] [Abstract][Full Text] [Related]
16. Comparison of alcoholic chlorhexidine and povidone-iodine cutaneous antiseptics for the prevention of central venous catheter-related infection: a cohort and quasi-experimental multicenter study.
Pages J; Hazera P; Mégarbane B; du Cheyron D; Thuong M; Dutheil JJ; Valette X; Fournel F; Mermel LA; Mira JP; Daubin C; Parienti JJ;
Intensive Care Med; 2016 Sep; 42(9):1418-26. PubMed ID: 27311311
[TBL] [Abstract][Full Text] [Related]
17. Vascular catheter infections: time to get technical.
Chopra V; Saint S
Lancet; 2015 Nov; 386(10008):2034-2036. PubMed ID: 26388530
[No Abstract] [Full Text] [Related]
18. Arterial catheter-related bloodstream infection: incidence, pathogenesis, risk factors and prevention.
Safdar N; O'Horo JC; Maki DG
J Hosp Infect; 2013 Nov; 85(3):189-95. PubMed ID: 24070632
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
[TBL] [Abstract][Full Text] [Related]
20. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery.
Dumville JC; McFarlane E; Edwards P; Lipp A; Holmes A
Cochrane Database Syst Rev; 2013 Mar; (3):CD003949. PubMed ID: 23543526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
